Related Experiment Video
Updated: May 16, 2026
Methods to Inhibit Bacterial Pyomelanin Production and Determine the Corresponding Increase in Sensitivity to Oxidative Stress
Published on: August 31, 2015
Minocycline-induced hyperpigmentation in multibacillary leprosy.
Stephanie W Hu1, Maria R Robinson, Tracey Newlove
1Department of Dermatology, New York University, New York, NY 10016, USA. stephwhu@gmail.com
Minocycline-induced hyperpigmentation in leprosy patients may present with new patterns. This study suggests additional subtypes of this adverse effect beyond the classic three clinical types.
Area of Science:
- Dermatology
- Pharmacology
- Infectious Diseases
Background:
- Minocycline is effective against Mycobacterium leprae, the causative agent of leprosy.
- Hyperpigmentation is a known adverse effect of minocycline therapy.
- Classic minocycline-induced hyperpigmentation is categorized into three clinical and histological patterns.
More Related Videos
10:32Optimized Protocols for Mycobacterium leprae Strain Management: Frozen Stock Preservation and Maintenance in Athymic Nude Mice
Published on: March 23, 2014
03:47Enhancement of Facial Rejuvenation Through a Combination of 1565 nm Non-Ablative Fractional Laser with 30% Supramolecular Salicylic Acid
Published on: September 27, 2024